Form 4: RA Capital Management Reports Stock Option Award in Mineralys Therapeutics

RA Capital Management and related parties report the acquisition of a stock option award in Mineralys Therapeutics, Inc.

Summary

• RA Capital Management, L.P., along with related entities and individuals, filed a Form 4 detailing changes in beneficial ownership of Mineralys Therapeutics, Inc. securities.
• The report discloses the acquisition of a stock option for 22,000 shares of common stock at an exercise price of $12.52 on May 22, 2024.
• The stock option vests in 12 substantially equal monthly installments starting June 22, 2024, with accelerated vesting under certain conditions related to the annual stockholder meeting.
• RA Capital Management, L.P. acts as the investment manager for RA Capital Healthcare Fund, L.P. and RA Capital Nexus III Fund, L.P.
• The reporting persons, including RA Capital Management entities and individuals Peter Kolchinsky and Rajeev Shah, disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest.
• Derek DiRocco, a Partner of the Adviser, holds the option for the benefit of the Fund and the Nexus Fund III and is obligated to turn over any proceeds to offset advisory fees.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral.

Management Comments

• RA Capital Management, L.P., the Adviser, is the investment manager for RA Capital Healthcare Fund, L.P. and RA Capital Nexus III Fund, L.P.
• The Adviser, the Adviser GP, the Fund, the Nexus Fund III, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
• Derek DiRocco is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option, which will offset advisory fees owed by the Fund and the Nexus Fund III to the Adviser.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders and significant shareholders, providing transparency to the market.

Key Dates